Nanfang Hospital, Southern Medical University clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 3 with minor changes only.

1. Minor

   Adebrelimab Combined With Chemoradiotherapy · Unresectable Locally…Adebrelimab Combined With Chemoradiotherapy · Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma

   Enrollment closed, study ongoing

   Also in this update: Interventions modified

   Nanfang Hospital, Southern Medical University·Phase 2· NCT06885814· Registry history of NCT06885814 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

2. Minor

   Autologous Fat Grafting in Improving Hair Transplantation Outcomes…Autologous Fat Grafting in Improving Hair Transplantation Outcomes · Localized Scleroderma-Related Alopecia

   Completed without a posted recruiting period

   Also in this update: Primary completion date changed from estimate of Apr 1, 2026 to Sep 3, 2026

   Nanfang Hospital, Southern Medical University·Not applicable· NCT06646146· Registry history of NCT06646146 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

3. Minor

   Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and…Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

   Registry marked status Unknown (sponsor has not verified the record since Dec 2023); last known: Recruiting

   Nanfang Hospital, Southern Medical University·Phase 2· NCT06177925· Registry history of NCT06177925 on ClinicalTrials.gov (opens the registry)

   Changed Oct 4, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.